Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Sulphonamides market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.9% during the forecast period.
This report presents the market size and development trends by detailing the Sulphonamides market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Sulphonamides market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Sulphonamides industry and will help you to build a panoramic view of the industrial development.
Sulphonamides Market, By Type:
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Sulphonamides Market, By Application:
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Some of the leading players are as follows:
Bayer AG
Roche Holding AG
Sanofi Aventis
GlaxoSmithKline
Mylan Pharmaceuticals
Pfizer
Abbott Laboratories
Par Pharmaceutical
Stiefel Laboratories
King Pharmaceuticals
Boehringer Ingelheim Pharmaceuticals
Novartis International AG
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Sulphonamides Market: Technology Type Analysis
-
4.1 Sulphonamides Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Sulphonamides Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Orally Absorbable Sulfonamide
4.3.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
4.3.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
5 Sulphonamides Market: Product Analysis
-
5.1 Sulphonamides Product Market Share Analysis, 2018 & 2026
-
5.2 Sulphonamides Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Sulphonamides Market: Application Analysis
-
6.1 Sulphonamides Application Market Share Analysis, 2018 & 2026
-
6.2 Sulphonamides Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Skin Infections
6.3.2 Gastro Intestinal Tract (GIT) Infection
6.3.3 Meningitis
7 Sulphonamides Market: Regional Analysis
-
7.1 Sulphonamides Regional Market Share Analysis, 2018 & 2026
-
7.2 Sulphonamides Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Bayer AG
9.1.1 Bayer AG Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Roche Holding AG
9.2.1 Roche Holding AG Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Sanofi Aventis
9.3.1 Sanofi Aventis Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 GlaxoSmithKline
9.4.1 GlaxoSmithKline Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Mylan Pharmaceuticals
9.5.1 Mylan Pharmaceuticals Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Pfizer
9.6.1 Pfizer Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Abbott Laboratories
9.7.1 Abbott Laboratories Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Par Pharmaceutical
9.8.1 Par Pharmaceutical Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Stiefel Laboratories
9.9.1 Stiefel Laboratories Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 King Pharmaceuticals
9.10.1 King Pharmaceuticals Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Boehringer Ingelheim Pharmaceuticals
9.11.1 Boehringer Ingelheim Pharmaceuticals Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Novartis International AG
9.12.1 Novartis International AG Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 73 Figures and 150 Tables)
Figure Orally Absorbable Sulfonamide Sulphonamides market, 2015 - 2026 (USD Million)
Figure Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Sulphonamides market, 2015 - 2026 (USD Million)
Figure Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Sulphonamides market, 2015 - 2026 (USD Million)
Figure Skin Infections market, 2015 - 2026 (USD Million)
Figure Gastro Intestinal Tract (GIT) Infection market, 2015 - 2026 (USD Million)
Figure Meningitis market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Sulphonamides market, by country, 2015 - 2026 (USD Million)
-
Table North America Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table North America Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table North America Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Canada Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Canada Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Europe Sulphonamides market, by country, 2015 - 2026 (USD Million)
-
Table Europe Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Europe Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Europe Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Germany Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Germany Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table France Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table France Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Italy Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Italy Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Spain Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Spain Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sulphonamides market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table China Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table China Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Japan Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Japan Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table India Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table India Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Sulphonamides market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table MEA Sulphonamides market, by country, 2015 - 2026 (USD Million)
-
Table MEA Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table MEA Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table MEA Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Sulphonamides market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Sulphonamides market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Sulphonamides market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Bayer AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Holding AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Aventis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Par Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Stiefel Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table King Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis International AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
